Latest Insider Transactions at Phase Bio Pharmaceuticals Inc (PHAS)
This section provides a real-time view of insider transactions for Phase Bio Pharmaceuticals Inc (PHAS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PhaseBio Pharmaceuticals Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PhaseBio Pharmaceuticals Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 19
2023
|
Nancy J Hutson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+9.09%
|
-
|
|
May 19
2023
|
Caroline M Loewy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+50.0%
|
-
|
|
May 19
2023
|
Alex Sapir Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+50.0%
|
-
|
|
May 19
2023
|
Edmund Harrigan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+27.78%
|
-
|
|
May 19
2023
|
William D. Humphries Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,538
+50.0%
|
-
|
|
May 19
2023
|
Clay Thorp Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+9.27%
|
-
|
|
May 19
2023
|
Richard Van Den Broek Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,750
+100.0%
|
-
|
|
Oct 25
2022
|
New Enterprise Associates 13 LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,784,109
-26.86%
|
$0
$0.15 P/Share
|
|
May 23
2022
|
Glen Burkhardt SVP of Human Resources |
SELL
Open market or private sale
|
Direct |
11,248
-100.0%
|
$0
$0.79 P/Share
|
|
May 20
2022
|
John P Sharp Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,026
+8.39%
|
$0
$0.68 P/Share
|
|
May 20
2022
|
Jonathan Birchall Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
$0
$0.68 P/Share
|
|
May 20
2022
|
Kristopher Hanson SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,831
+36.34%
|
$0
$0.68 P/Share
|
|
May 20
2022
|
Glen Burkhardt SVP of Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
11,248
+50.0%
|
$0
$0.68 P/Share
|
|
May 20
2022
|
Jonathan P Mow Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,918
+7.61%
|
$0
$0.68 P/Share
|
|
May 20
2022
|
Susan Elizabeth Arnold SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
10,917
+20.93%
|
$0
$0.68 P/Share
|
|
Nov 19
2021
|
Glen Burkhardt SVP of Human Resources |
SELL
Open market or private sale
|
Direct |
5,766
-100.0%
|
$11,532
$2.37 P/Share
|
|
Nov 19
2021
|
Glen Burkhardt SVP of Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
5,766
+50.0%
|
$11,532
$2.01 P/Share
|
|
Nov 19
2021
|
Kristopher Hanson SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,545
+29.84%
|
$3,090
$2.01 P/Share
|
|
Nov 19
2021
|
John P Sharp Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,017
+3.27%
|
$4,034
$2.01 P/Share
|
|
Nov 19
2021
|
Susan Elizabeth Arnold SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
2,559
+7.78%
|
$5,118
$2.01 P/Share
|
|
Nov 19
2021
|
Jonathan P Mow Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,623
+3.16%
|
$11,246
$2.01 P/Share
|
|
Nov 08
2021
|
Nancy J Hutson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,400
+17.98%
|
$22,200
$3.15 P/Share
|
|
Nov 05
2021
|
Nancy J Hutson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
26,360
+27.69%
|
$52,720
$2.71 P/Share
|
|
Nov 03
2021
|
John P Sharp Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+11.5%
|
$7,500
$1.68 P/Share
|
|
Nov 03
2021
|
Jonathan P Mow Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.7%
|
$20,000
$1.24 P/Share
|
|
Aug 27
2021
|
Jonathan P Mow Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+11.99%
|
$20,000
$1.24 P/Share
|
|
Aug 18
2021
|
Nancy J Hutson Director |
BUY
Open market or private purchase
|
Indirect |
3,000
+42.86%
|
$9,000
$3.08 P/Share
|
|
Aug 18
2021
|
Clay Thorp Director |
BUY
Open market or private purchase
|
Direct |
10,000
+23.29%
|
$30,000
$3.0 P/Share
|
|
Aug 03
2021
|
John P Sharp Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+12.99%
|
$7,500
$1.68 P/Share
|
|
Jul 12
2021
|
Susan Elizabeth Arnold SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
4,519
+14.0%
|
$4,519
$1.74 P/Share
|
|
May 20
2021
|
Kristopher Hanson SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,088
+34.27%
|
$2,176
$2.8 P/Share
|
|
May 20
2021
|
Susan Elizabeth Arnold SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
5,257
+18.45%
|
$10,514
$2.8 P/Share
|
|
May 20
2021
|
Michael York VP, Corporate Development |
BUY
Grant, award, or other acquisition
|
Direct |
2,897
+29.1%
|
$5,794
$2.8 P/Share
|
|
May 20
2021
|
Jonathan P Mow Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,964
+3.03%
|
$7,928
$2.8 P/Share
|
|
May 20
2021
|
Glen Burkhardt SVP of Human Resources |
SELL
Open market or private sale
|
Direct |
3,811
-100.0%
|
$11,433
$3.29 P/Share
|
|
May 20
2021
|
Glen Burkhardt SVP of Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
3,811
+50.0%
|
$7,622
$2.8 P/Share
|
|
May 20
2021
|
John P Sharp Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,419
+3.21%
|
$2,838
$2.8 P/Share
|
|
Dec 03
2020
|
Edmund Harrigan Director |
BUY
Open market or private purchase
|
Direct |
6,000
+50.0%
|
$24,000
$4.12 P/Share
|
|
Nov 24
2020
|
Clay Thorp Director |
BUY
Open market or private purchase
|
Direct |
2,000
+8.02%
|
$6,000
$3.5 P/Share
|
|
Nov 23
2020
|
Clay Thorp Director |
BUY
Open market or private purchase
|
Direct |
3,000
+12.53%
|
$9,000
$3.67 P/Share
|
|
Nov 23
2020
|
Glen Burkhardt SVP of Human Resources |
SELL
Open market or private sale
|
Direct |
3,497
-100.0%
|
$10,491
$3.45 P/Share
|
|
Nov 20
2020
|
Glen Burkhardt SVP of Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
3,497
+50.0%
|
$10,491
$3.0 P/Share
|
|
Nov 20
2020
|
Jonathan P Mow Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,643
+2.88%
|
$10,929
$3.0 P/Share
|
|
Nov 20
2020
|
Susan Elizabeth Arnold SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
4,832
+21.18%
|
$14,496
$3.0 P/Share
|
|
Nov 20
2020
|
David James Ballance VP, Research and Sci. Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
919
+9.74%
|
$2,757
$3.0 P/Share
|
|
Nov 20
2020
|
Michael York VP, Corporate Development |
BUY
Grant, award, or other acquisition
|
Direct |
2,662
+39.01%
|
$7,986
$3.0 P/Share
|
|
Nov 20
2020
|
Kristopher Hanson SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
999
+50.0%
|
$2,997
$3.0 P/Share
|
|
Nov 20
2020
|
John P Sharp Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,305
+3.06%
|
$3,915
$3.0 P/Share
|
|
Nov 16
2020
|
Clay Thorp Director |
BUY
Other acquisition or disposition
|
Indirect |
10,586
+40.69%
|
-
|
|
Nov 16
2020
|
Clay Thorp Director |
BUY
Other acquisition or disposition
|
Direct |
2,144
+10.67%
|
-
|